Ireland - English - HPRA (Health Products Regulatory Authority)

regivet bv - potassium bromide - tablet - 600 milligram(s) - potassium bromide

United Kingdom - English - VMD (Veterinary Medicines Directorate)

regivet bv - potassium bromide - tablet - neurological agent antiepileptic - dogs

Malta - English - Medicines Authority

bioorganics bv microweg 22, 6545cm nijmegen, netherlands - sugammadex - solution for injection - sugammadex 100 mg/ml - all other therapeutic products

European Union - English - EMA (European Medicines Agency)

amgen europe bv - trastuzumab - stomach neoplasms; breast neoplasms - antineoplastic agents - metastatic breast cancerkanjinti is indicated for the treatment of adult patients with her2 positive metastatic breast cancer (mbc):as monotherapy for the treatment of those patients who have received at least two chemotherapy regimens for their metastatic disease. prior chemotherapy must have included at least an anthracycline and a taxane unless patients are unsuitable for these treatments. hormone-receptor positive patients must also have failed hormonal therapy, unless patients are unsuitable for these treatments.in combination with paclitaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease and for whom an anthracycline is not suitable.in combination with docetaxel for the treatment of those patients who have not received chemotherapy for their metastatic disease.in combination with an aromatase inhibitor for the treatment of postmenopausal patients with hormone-receptor positive mbc, not previously treated with trastuzumab.early breast cancerkanjinti is indicated for the treatment of adult patients with her2 positive early breast cancer (ebc):following surgery, chemotherapy (neoadjuvant or adjuvant) and radiotherapy (if applicable).following adjuvant chemotherapy with doxorubicin and cyclophosphamide, in combination with paclitaxel or docetaxel.in combination with adjuvant chemotherapy consisting of docetaxel and carboplatin.in combination with neoadjuvant chemotherapy followed by adjuvant kanjinti therapy, for locally advanced (including inflammatory) disease or tumours > 2 cm in diameter.kanjinti should only be used in patients with metastatic or early breast cancer whose tumours have either her2 overexpression or her2 gene amplification as determined by an accurate and validated assay.metastatic gastric cancerkanjinti in combination with capecitabine or 5-fluorouracil and cisplatin is indicated for the treatment of adult patients with her2 positive metastatic adenocarcinoma of the stomach or gastroesophageal junction who have not received prior anti-cancer treatment for their metastatic disease.kanjinti should only be used in patients with metastatic gastric cancer (mgc) whose tumours have her2 overexpression as defined by ihc 2+ and a confirmatory sish or fish result, or by an ihc 3+ result. accurate and validated assay methods should be used.

Canada - English - Health Canada

regime industries ltd. - manganese (manganese citrate); silicon (equisetum arvense); ascorbic acid (ascorbic acid); vitamin d3; vitamin b6 (pyridoxine hydrochloride); calcium (calcium citrate, calcium hvp chelate); magnesium (magnesium citrate, magnesium oxide); zinc (zinc citrate) - capsule - 2mg; .25mg; 25mg; 100unit; 5mg; 150mg; 75mg; 3mg - manganese (manganese citrate) 2mg; silicon (equisetum arvense) .25mg; ascorbic acid (ascorbic acid) 25mg; vitamin d3 100unit; vitamin b6 (pyridoxine hydrochloride) 5mg; calcium (calcium citrate, calcium hvp chelate) 150mg; magnesium (magnesium citrate, magnesium oxide) 75mg; zinc (zinc citrate) 3mg - vitamins & minerals

Canada - English - Health Canada

regime industries ltd. - beta-carotene (provitamin a); vitamin a (retinol palmitate); vitamin d3; vitamin b1 (thiamine hydrochloride); vitamin b2 (riboflavin); nicotinic acid; nicotinamide; vitamin b6 (pyridoxine hydrochloride); vitamin b12 (cyanocobalamin); d-pantothenic acid (calcium d-pantothenate); folic acid; biotin; ascorbic acid (ascorbic acid); vitamin e (d-alpha tocopheryl acid succinate); inositol; calcium (calcium carbonate, calcium citrate); magnesium (magnesium oxide, magnesium citrate); potassium (potassium citrate); zinc (zinc citrate); manganese (manganese citrate); iodine (kelp); chromium (chromium hvp chelate); selenium (selenium hvp chelate); vanadium (vanadium citrate); molybdenum (molybdenum citrate); silicon (horsetail) - capsule - 1250unit; 1250unit; 100unit; 4.25mg; 2.5mg; 5mg; 85mg; 10mg; 50mcg; 10mg; 0.2mg; 50mcg; 50mg; 50unit; 7.5mg; 75mg; 75mg; 10mg; 1.25mg; 0.5mg; 0.25mg; 50mcg; 25mcg; 7.5mcg; 2.5mcg; 0.5mg - beta-carotene (provitamin a) 1250unit; vitamin a (retinol palmitate) 1250unit; vitamin d3 100unit; vitamin b1 (thiamine hydrochloride) 4.25mg; vitamin b2 (riboflavin) 2.5mg; nicotinic acid 5mg; nicotinamide 85mg; vitamin b6 (pyridoxine hydrochloride) 10mg; vitamin b12 (cyanocobalamin) 50mcg; d-pantothenic acid (calcium d-pantothenate) 10mg; folic acid 0.2mg; biotin 50mcg; ascorbic acid (ascorbic acid) 50mg; vitamin e (d-alpha tocopheryl acid succinate) 50unit; inositol 7.5mg; calcium (calcium carbonate, calcium citrate) 75mg; magnesium (magnesium oxide, magnesium citrate) 75mg; potassium (potassium citrate) 10mg; zinc (zinc citrate) 1.25mg; manganese (manganese citrate) 0.5mg; iodine (kelp) 0.25mg; chromium (chromium hvp chelate) 50mcg; selenium (selenium hvp chelate) 25mcg; vanadium (vanadium citrate) 7.5mcg; molybdenum (molybdenum citrate) 2.5mcg; silicon (horsetail) 0.5mg - vitamins & minerals

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - norethindrone (unii: t18f433x4s) (norethindrone - unii:t18f433x4s), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - norethindrone 0.5 mg - nortrel™ 7/7/7 (norethindrone and ethinyl estradiol tablets, usp 0.5/0.035 mg, 0.75/0.035 mg, and 1/0.035 mg) (21 day regimen and 28 day regimen) are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception. oral contraceptives are highly effective. table i lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception. the efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. correct and consistent use of methods can result in lower failure rates. method typical use perfect use oral contraceptives should not be used in women who currently have the following conditions: - thrombophlebitis or thromboembolic disorders - a past history of deep vein thrombophlebitis or thromboembolic disorders - cerebral vascular or coronary artery disease - known or suspected carcinoma of the breast - carcinoma of the endometrium or other known or susp

United States - English - NLM (National Library of Medicine)

pss world medical, inc. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic to decrease bacteria on the skin. recommended for repeated use.

United States - English - NLM (National Library of Medicine)

healthlink - chloroxylenol (unii: 0f32u78v2q) (chloroxylenol - unii:0f32u78v2q) - antimicrobial - specially formulated for the sensitive skin of today's healthcare professional - protects hands from germs and bacteria - antimicrobial hand cleaner - for repeated washings on a daily basis

European Union - English - EMA (European Medicines Agency)

viiv healthcare bv - lamivudine - hiv infections - antivirals for systemic use - epivir is indicated as part of antiretroviral combination therapy for the treatment of human-immunodeficiency-virus (hiv)-infected adults and children.,